Seminole Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-302,709
Closed -$10.3M 34
2017
Q3
$10.3M Buy
+302,709
New +$9.73M 2.2% 13
2016
Q4
Sell
-615,590
Closed -$19.8M 52
2016
Q3
$19.8M Sell
615,590
-57,274
-9% -$1.92M 3.39% 11
2016
Q2
$22.5M Buy
672,864
+262,840
+64% +$8.39M 2.28% 16
2016
Q1
$11.5M Buy
+410,024
New +$11.7M 0.93% 32
2015
Q4
Sell
-3,014,132
Closed -$89.8M 43
2015
Q3
$89.8M Buy
3,014,132
+888,214
+42% +$28.5M 4.01% 12
2015
Q2
$67.6M Buy
2,125,918
+554,035
+35% +$18.1M 2.73% 12
2015
Q1
$51.9M Buy
+1,571,883
New +$50M 2.33% 13

Other funds holding PFE

Seminole Management's PFE Position: Q4 2017 in Review

Seminole Management sold out of Pfizer (PFE) in Q4 2017, closing a stake of 302,709 shares — an estimated $10.3M sold.

Seminole Management first reported a position in PFE in Q1 2015 and held it in 7 quarters. The position peaked at $89.8M in Q3 2015. 2,243 funds tracked by Wall St. Rank hold PFE as of Q4 2017.

  • Seminole Management reported no remaining Pfizer position as of Q4 2017 after selling out during the quarter.
  • Seminole Management sold 302,709 Pfizer shares in Q4 2017, an estimated $10.3M.
  • Seminole Management first reported a position in Pfizer in Q1 2015 and held it in 7 quarters.
  • Seminole Management's Pfizer position peaked at $89.8M in Q3 2015.
  • 2,243 funds tracked by Wall St. Rank held Pfizer as of Q4 2017.

Based on Seminole Management's 13F filing for Q4 2017, filed 29 Jan 2018.